In conclusion, in COVID-19 the EGCG/GTE supplementation should be advantageous because of their multitarget action as regulators of both transcription factor (i.e., STAT1, STAT3, NF-κB, Nrf2) activities and expression of their target genes (Figure 1). The gene discussed is NFKB1; the disease is COVID-19.